Nothing Special   »   [go: up one dir, main page]

Mancera-Rincón et al., 2024 - Google Patents

Maturity-onset diabetes of the young type 7 (MODY7) and the krüppellike factor 11 mutation (KLF11). A review

Mancera-Rincón et al., 2024

Document ID
7074409450028950076
Author
Mancera-Rincón P
Luna-España M
Rincon O
Guzmán I
Alvarez M
Publication year
Publication venue
Current Diabetes Reviews

External Links

Snippet

Introduction: Maturity-onset diabetes of the young (MODY) is a rare disease due to a single gene mutation that affects several family members in most cases. The Krüppel-like factor 11 (KLF11) gene mutation is associated with decreased insulin sensitivity to high glucose …
Continue reading at www.ingentaconnect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material

Similar Documents

Publication Publication Date Title
Urakami Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment
Umpierrez et al. Narrative review: ketosis-prone type 2 diabetes mellitus
Vaxillaire et al. Genetic basis of maturity-onset diabetes of the young
Yorifuji et al. Comprehensive molecular analysis of Japanese patients with pediatric‐onset MODY‐type diabetes mellitus
den Uyl et al. Metabolic effects of high‐dose prednisolone treatment in early rheumatoid arthritis: Balance between diabetogenic effects and inflammation reduction
Nishimura et al. Slowly progressive type 1 diabetes mellitus: current knowledge and future perspectives
Yahaya et al. Genetics and pathophysiology of maturity-onset diabetes of the young (MODY): A Review of current trends
Mohan et al. Associations of β-cell function and insulin resistance with youth-onset type 2 diabetes and prediabetes among Asian Indians
Hegele et al. Genetic and physiological insights into the metabolic syndrome
Schmid et al. Globular and full-length adiponectin induce NO-dependent vasodilation in resistance arteries of Zucker lean but not Zucker diabetic fatty rats
Wojcik et al. The elevated gene expression level of the A2B adenosine receptor is associated with hyperglycemia in women with gestational diabetes mellitus
Oliveira et al. Maturity-onset diabetes of the young: from a molecular basis perspective toward the clinical phenotype and proper management
Yew et al. tRNA methyltransferase homologue gene TRMT 10A mutation in young adult‐onset diabetes with intellectual disability, microcephaly and epilepsy
Miranda‐Lora et al. Associations of common variants in the SLC16A11, TCF7L2, and ABCA1 genes with pediatric‐onset type 2 diabetes and related glycemic traits in families: a case‐control and case‐parent trio study
Moon et al. Genetic polymorphisms in peroxisome proliferator‐activated receptor γ are associated with Type 2 diabetes mellitus and obesity in the Korean population
Yeow et al. Preserved glucagon-like peptide-1 responses to oral glucose, but reduced incretin effect, insulin secretion and sensitivity in young Asians with type 2 diabetes mellitus
Andersen et al. PGC-1α Gly482Ser polymorphism associates with hypertension among Danish whites
Harsunen et al. Identification of monogenic variants in more than ten per cent of children without type 1 diabetes-related autoantibodies at diagnosis in the Finnish Pediatric Diabetes Register
Bertoccini et al. The vitamin D receptor functional variant rs2228570 (C> T) does not associate with type 2 diabetes mellitus
Opstad et al. Reduced leukocyte telomere lengths and sirtuin 1 gene expression in long‐term survivors of type 1 diabetes: A Dialong substudy
Mancera-Rincón et al. Maturity-onset diabetes of the young type 7 (MODY7) and the krüppellike factor 11 mutation (KLF11). A review
Yamakage et al. Association of protein tyrosine phosphatase 1B gene polymorphism with the effects of weight reduction therapy on bodyweight and glycolipid profiles in obese patients
Montagnana et al. The Pro12Ala polymorphism of the PPARG gene is not associated with the metabolic syndrome in an urban population of middle‐aged Swedish individuals
Gomathi et al. The-866G/A polymorphism in the promoter of the UCP2 gene is associated with risk for type 2 diabetes and with decreased insulin levels
Langer et al. The novel GCK variant p. Val455Leu associated with hyperinsulinism is susceptible to allosteric activation and is conducive to weight gain and the development of diabetes